| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Lineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599;
SyStemix, Inc., Palo Alto, CA 94304; and
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY 10016
The SCID-hu Thy/Liv mouse and human fetal thymic organ culture (HF-TOC) models have been used to explore the pathophysiologic mechanisms of HIV-1 infection in the thymus. We report here that HIV-1 infection of the SCID-hu Thy/Liv mouse leads to the induction of MHC class I (MHCI) expression on CD4+CD8+ (DP) thymocytes, which normally express low levels of MHCI. Induction of MHCI on DP thymocytes in HIV-1-infected Thy/Liv organs precedes their depletion and correlates with the pathogenic activity of the HIV-1 isolates. Both MHCI protein and mRNA are induced in thymocytes from HIV-1-infected Thy/Liv organs, indicating induction of MHCI gene expression. Indirect mechanisms are involved, because only a fraction (<10%) of the DP thymocytes were directly infected by HIV-1, although the majority of DP thymocytes are induced to express high levels of MHCI. We further demonstrate that IL-10 is induced in HIV-1-infected thymus organs. Similar HIV-1-mediated induction of MHCI expression was observed in HF-TOC assays. Exogenous IL-10 in HF-TOC induces MHCI expression on DP thymocytes. Therefore, HIV-1 infection of the thymus organ leads to induction of MHCI expression on immature thymocytes via indirect mechanisms involving IL-10. Overexpression of MHCI on DP thymocytes can interfere with thymocyte maturation and may contribute to HIV-1-induced thymocyte depletion.
This article has been cited by other articles:
|
|
 |
|
  S. K. Choudhary, N. R. Choudhary, K. C. Kimbrell, J. Colasanti, A. Ziogas, D. Kwa, H. Schuitemaker, and D. Camerini R5 Human Immunodeficiency Virus Type 1 Infection of Fetal Thymic Organ Culture Induces Cytokine and CCR5 Expression J. Virol., January 1, 2005; 79(1): 458 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Gurney, A. D. Colantonio, B. Blom, H. Spits, and C. H. Uittenbogaart Endogenous IFN-{alpha} Production by Plasmacytoid Dendritic Cells Exerts an Antiviral Effect on Thymic HIV-1 Infection J. Immunol., December 15, 2004; 173(12): 7269 - 7276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Brilot, V. Geenen, D. Hober, and C. A. Stoddart Coxsackievirus B4 Infection of Human Fetal Thymus Cells J. Virol., September 15, 2004; 78(18): 9854 - 9861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Darwich, S. Pie, A. Rovira, J. Segales, M. Domingo, I. P. Oswald, and E. Mateu Cytokine mRNA expression profiles in lymphoid tissues of pigs naturally affected by postweaning multisystemic wasting syndrome J. Gen. Virol., August 1, 2003; 84(8): 2117 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Keir, M. G. Rosenberg, J. K. Sandberg, K. A. Jordan, A. Wiznia, D. F. Nixon, C. A. Stoddart, and J. M. McCune Generation of CD3+CD8low Thymocytes in the HIV Type 1-Infected Thymus J. Immunol., September 1, 2002; 169(5): 2788 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Brooks and J. A. Zack Effect of Latent Human Immunodeficiency Virus Infection on Cell Surface Phenotype J. Virol., February 15, 2002; 76(4): 1673 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Igarashi, C. R. Brown, R. A. Byrum, Y. Nishimura, Y. Endo, R. J. Plishka, C. Buckler, A. Buckler-White, G. Miller, V. M. Hirsch, et al. Rapid and Irreversible CD4+ T-Cell Depletion Induced by the Highly Pathogenic Simian/Human Immunodeficiency Virus SHIVDH12R Is Systemic and Synchronous J. Virol., January 1, 2002; 76(1): 379 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Keir, C. A. Stoddart, V. Linquist-Stepps, M. E. Moreno, and J. M. McCune IFN-{alpha} Secretion by Type 2 Predendritic Cells Up-Regulates MHC Class I in the HIV-1-Infected Thymus J. Immunol., January 1, 2002; 168(1): 325 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Strizki, S. Xu, N. E. Wagner, L. Wojcik, J. Liu, Y. Hou, M. Endres, A. Palani, S. Shapiro, J. W. Clader, et al. SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo PNAS, October 12, 2001; (2001) 221375398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Miller, K. M. Duus, M. Townsend, Y. Yi, R. Collman, M. Reitz, and L. Su Human Immunodeficiency Virus Type 1 IIIB Selected for Replication In Vivo Exhibits Increased Envelope Glycoproteins in Virions without Alteration in Coreceptor Usage: Separation of In Vivo Replication from Macrophage Tropism J. Virol., September 15, 2001; 75(18): 8498 - 8506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Duus, E. D. Miller, J. A. Smith, G. I. Kovalev, and L. Su Separation of Human Immunodeficiency Virus Type 1 Replication from nef-Mediated Pathogenesis in the Human Thymus J. Virol., April 15, 2001; 75(8): 3916 - 3924. [Abstract] [Full Text]
|
|
|
|
|
|
M. Rosenzweig, M. Connole, A. Forand-Barabasz, M.-P. Tremblay, R. P. Johnson, and A. A. Lackner Mechanisms Associated with Thymocyte Apoptosis Induced by Simian Immunodeficiency Virus J. Immunol., September 15, 2000; 165(6): 3461 - 3468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Scoggins, J. R. Taylor Jr., J. Patrie, A. B. van't Wout, H. Schuitemaker, and D. Camerini Pathogenesis of Primary R5 Human Immunodeficiency Virus Type 1 Clones in SCID-hu Mice J. Virol., April 1, 2000; 74(7): 3205 - 3216. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Strizki, S. Xu, N. E. Wagner, L. Wojcik, J. Liu, Y. Hou, M. Endres, A. Palani, S. Shapiro, J. W. Clader, et al. SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo PNAS, October 23, 2001; 98(22): 12718 - 12723. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
